Project Grant R21AG093623
- Federal Grant Award Summary The University of Minnesota, operating through its Office of Sponsored Projects Administration, received a $423,500 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective February 1, 2026, through January 31, 2028. The award funds research on the functional characterization of adipocyte-derived lipocalin 2-containing extracellular vesicles in senescence, with research activities conducted in St. Paul,...
- Federal Grant Award Summary Fred Hutchinson Cancer Center received a $2.59 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded September 15, 2025, with completion targeted for August 31, 2029. The grant funds fundamental research to elucidate mechanisms of adipocyte-brain communication and their impact on glial function, neuroprotection, and brain aging, with potential implications for preventing dementia and age-related...
- Federal Grant Award Summary This Project Grant award of $109,076, issued on March 3, 2026, by the National Institute on Aging under the Aging Research program (CFDA 93.866), supports research investigating vulnerable cell populations in aging-induced circadian clock remodeling and disruption through March 2029. The primary deliverable is a comprehensive scientific investigation utilizing high-throughput single-nucleus RNA sequencing (snRNA-seq) of flash-frozen tissue samples to identify key cell...
- Federal Grant Award Summary The Buck Institute for Research on Aging received $809,486 in Project Grant funding from the National Institute on Aging (CFDA 93.866 – Aging Research program) beginning February 1, 2026, through January 31, 2031. The award supports comprehensive biomedical research investigating the role of oxidation resistance 1 (OXR1) and retromer proteins in brain aging and Alzheimer's disease and related dementias (ADRD). The research leverages multiple model systems, including...
- Federal Grant Award Summary The National Institute on Aging awarded The Trustees of Columbia University in the City of New York a $690,865 Project Grant (CFDA 93.866 - Aging Research) effective January 15, 2026, with completion targeted for December 31, 2030. This award supports a comprehensive research initiative examining the mitochondrial and energetic underpinnings of resilience in human aging. The research leverages two unique human datasets—the MISBIE Study (which includes patients with...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the Regents of the University of Minnesota $645,743 under the Aging Research program (CFDA 93.866) to conduct a longitudinal epidemiological study examining the relationship between childhood socioeconomic status (SES) and lead (Pb) exposure on dementia risk in later life. The project, spanning February 1, 2026 through December 31, 2030, creates a novel research data source by linking approximately 15,792...
- Federal Project Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $2,991,725 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) effective September 1, 2025, with a completion date of August 31, 2029. This award funds a comprehensive research initiative investigating reactive oxygen species (ROS) as modulators of lifespan and aging processes. The research examines how early-life...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded $2.5 million to the University of Minnesota under the Aging Research program (CFDA 93.866) to conduct a longitudinal research study examining the relationship between housing policy, neighborhood context, and midlife mortality outcomes. Awarded on September 15, 2025, with a completion date of September 14, 2029, this four-year project delivers epidemiological research services that leverage data from the Moving...
- Federal Grant Award Summary The National Institutes of Health Office of the Director awarded $1,311,772 through the Trans-NIH Research Support program (CFDA 93.310) to the Regents of the University of Minnesota, with an award date of September 30, 2025, and completion date of August 31, 2028. This Director's New Innovator Award (DP2) funds research investigating neuroplasticity and cerebral blood flow mechanisms in "fast-moving superagers"—individuals aged 75 and older who maintain...
- Federal Grant Award Summary Mayo Clinic received a $441,100 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective August 1, 2025, through July 31, 2027. The award funds a multiomic analysis research initiative focused on characterizing the downstream molecular effects of telomere length across individual chromosome arms in healthy human cells and telomere biology disorder patients. Specifically, the research employs TeloGator, a novel...
The National Institute on Aging awarded the Regents of the University of Minnesota a $423,500 Project Grant under the Aging Research program (CFDA 93.866) effective February 1, 2026 through January 31, 2028. This award supports basic biomedical research investigating the mechanistic links between cyclin D1 protein expression, metabolic dysfunction, and aging processes. The research will utilize complementary model systems—including hepatocyte studies in mice and humans, as well as the nematode C. elegans—to define how age and overnutrition promote cyclin D1 expression independent of cell proliferation and how this protein regulates lipid catabolism pathways implicated in health and lifespan. The project employs novel genetic tools, including an auxin-induced degron system, to enable temporal and spatial manipulation of cyclin D1 expression for discovery of downstream metabolic mechanisms. This research addresses a significant public health priority by clarifying fundamental biological processes underlying age-related metabolic conditions, particularly obesity, type II diabetes, and metabolic dysfunction-associated steatotic liver disease. The work leverages established expertise at the University of Minnesota, a major research institution with extensive experience executing federally-funded biomedical research initiatives. Findings from this investigation may inform future therapeutic strategies targeting cell cycle-independent metabolic dysregulation in aging populations.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $423.5k | 1/16/26 |